Target intelligence / Profile preview

Immunoglobulin heavy variable group pseudogene

Molecular classification
Pseudogene, Immunoglobulin gene family, Variable region gene segment pseudogene
01

Overview

The "Immunoglobulin heavy variable group pseudogene" (gene symbol ENSG00000233105) refers to a pseudogene derivative within the immunoglobulin heavy chain variable (IGHV) group. Pseudogenes in the IGHV locus generally resemble variable region segments of immunoglobulin heavy chains but carry inactivating mutations such as stop codons or frameshifts that prevent expression of a functional protein. They do not produce active immunoglobulin chains and are not therapeutic targets. While such pseudogenes may contribute sequence diversity through gene conversion events, as suggested in genetic and immunology studies, they are not directly functional or druggable entities. This entry is not a conventional target such as a receptor, enzyme, or transporter, and thus is considered *incorrect* for therapeutic target applications. The term is a broad group descriptor for pseudogenes within the immunoglobulin heavy chain variable locus, rather than a specific, singular gene or druggable target. These pseudogenes contribute to the extensive diversity observed in the IGHV locus, which encodes the antigen-binding site of immunoglobulins (antibodies), but they themselves do not encode functional proteins. No biomarker, pharmacological, or disease-modifying role is assigned to this pseudogene entry. This gene name is listed in gene databases as a pseudogene and is not assigned functional targets in immunology or pharmacology resources.

Other names
IGHV pseudogeneImmunoglobulin heavy variable pseudogeneImmunoglobulin heavy chain variable region pseudogene

Beyond the preview

Go deeper on Immunoglobulin heavy variable group pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable group pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call